Navigation Links
Atrium shows a strong financial performance for its first quarter
Date:5/6/2008

the assumptions on which these forward-looking statements are based to be reasonable, but cautions the reader that these assumptions regarding future events, many of which are beyond its control, may ultimately prove to be incorrect since they are subject to risks and uncertainties that affect the Company. For additional information with respect to these and other factors, see the Company's quarterly and annual filings with the Canadian securities commissions. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, other than as required by law.

Attachment: Financial summary

Atrium Innovations Inc.

Summary of Interim Consolidated Financial Statements

(in millions of US dollars except per share amounts)

Consolidated Results for the quarters ended March 31

(unaudited)

2008 2007 Change

Revenues 65.8 35.9 83.2%

Gross Margin (1) 35.6 17.1 107.5%

54.1% 47.8%

EBITDA (2) 18.4 9.6 90.8%

28.0% 26.8%

Net Earnings from continuing operations 10.5 5.3 97.8%

Net Earnings form discontinued operations 4.2 3.3 27.3%

--- ---

Net earnings 14.7 8.6 70.8%

---- ---

Net earnings per share

Basic 0.46 0.28

Diluted 0.44 0.26

Cash
'/>"/>

SOURCE Atrium Innovations Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Atrium Innovations to Hold 2008 First Quarter Financial Results Conference Call and Webcast on May 6
2. Atrium Innovations to Hold 2007 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast on February 29
3. Atrium Announces a Significant Increase in Revenues and Earnings for the Third Quarter of 2007
4. Atrium Innovations to Hold 2007 Third Quarter Financial Results Conference Call and Webcast on November 8
5. Atrium Innovations Announces Management Changes
6. A Smoking Gene: deCODE Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence and Risk of Lung Cancer and Other Disease
7. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
8. Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention
9. UW paper in Science shows how some solids mimic liquids on nanoscale
10. New research shows that iPods do not interfere with cardiac pacemakers
11. New kind of transistor radios shows capability of nanotube technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 17, 2015 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD; ... that develops and commercializes proprietary technologies and products ... it has received approval from the TSX Venture ... common share purchase warrants ("the Warrants") of the ... Company,s May 2013 private placement financing. ...
(Date:4/17/2015)... LC Sciences LLC, a leading developer ... it is seeking beta testers for the VariantPro™ ... targeted sequencing technology. The system offers cost-effective, minimal ... detection of rare variants. It utilizes novel and ... will collaborate with beta testers to generate test ...
(Date:4/16/2015)... April 16, 2015 Cambridge ... solutions driven by Semantic Web technology, and ... information and services for the academic and scientific, ... its joint solution ‘Smart Data Lake for Clinical ... for the 2015 Bio-IT ‘Best of Show’ Award. ...
(Date:4/16/2015)... -- Schulman Associates IRB, Inc., the industry-leading central IRB in ... on Laboratory Drive in the heart of ... will house review board and service staff, which will ... customer service to clients. CBRE | ... deal, while Capital Associates Management, LLC represented the landlord.   ...
Breaking Biology Technology:SQI Diagnostics to Extend Warrant Expiry 2SQI Diagnostics to Extend Warrant Expiry 3LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 2LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 3Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 3Schulman IRB to Open Office in Research Triangle Park, N.C. 2
... Flulike Side-Effects Drives Physician Prescribing of Copaxone over an Interferon-Beta ... ... Resources, WALTHAM, Mass., March 11 ... focusing on pharmaceutical and,healthcare issues, finds that Teva Pharmaceutical,s Copaxone has ...
... 11 Altogen Biosystems,( http://www.altogen.com ) announced ... Las Vegas, NV, Altogen Custom Services focus ... Interference (RNAi) services, generation of stably-expressing cell,lines, ... the company will draw upon their unique ...
... Launch of Key ... Bavituximab Phase II Cancer Program-, TUSTIN, Calif., March 11 ... biopharmaceutical,company developing monoclonal antibodies for the treatment of cancer and,hepatitis ... quarter of fiscal year (FY) 2008 ended January 31, 2008. ...
Cached Biology Technology:Teva Pharmaceutical's Altered Peptide Ligand Copaxone Boasts the Greatest Patient Share Among First- and Second-Line Therapies for the Treatment of Multiple Sclerosis 2Teva Pharmaceutical's Altered Peptide Ligand Copaxone Boasts the Greatest Patient Share Among First- and Second-Line Therapies for the Treatment of Multiple Sclerosis 3Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services 2Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008 2Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008 3Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008 4Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008 5Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008 6Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008 7Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008 8Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008 9Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008 10
(Date:3/19/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market, announces its biometric payment technology, the Wocket® ... this week on Washington DC,s Fox ... segment "The Next Great Thing", host Laura Evans ... and ,a really big breakthrough in mobile payment.,  ...
(Date:3/17/2015)... March 17, 2015 MedNet Solutions ... in clinical study management systems, is pleased to ... at ARENA,s Outsourcing in Clinical Trials Southeast conference ... provides an excellent forum for MedNet to showcase ... affordable software-as-a-service (SaaS) eClinical technology platform. ...
(Date:3/17/2015)... , March 17, 2015  MecklerMedia Corporation ... largest exhibition for service robots ever held in ... takes place on May 11-13, 2015 at the ... exhibitors for the event include: Acorn Product Development; ... EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic Corporation; Neya ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
... songs of the humpback whale are among the most complex ... whales have their own syntax that uses sound units to ... last for hours. , Until now, only humans have demonstrated ... The research, published online in the March 2006 issue of ...
... grass inflorescence architecture because seeds of cereal grasses (e.g. ... , Grass seeds are borne on axillary branches, whose ... seen in the grasses. Maize produces two types of ... (female flowers and site of seed or kernel development). ...
... the neurotransmitter serotonin in the brain may also affect ... yet understood, say scientists from Georgetown University Medical Center ... investigators found, for the first time, that serotonin is ... that the chemical is specifically used to activate an ...
Cached Biology News:Warbling whales speak a language all their own 2Warbling whales speak a language all their own 3The evolution of food plants: Genetic control of grass flower architecture 2Commonly used antidepressants may also affect human immune system 2Commonly used antidepressants may also affect human immune system 3